Digicon

@if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif

@if (isset(session()->get('doctor')['vCentralCode']))

Logout

@endif

@csrf

@if (isset(session()->get('doctor')['vCentralCode']))

Back

@else

@endif

Questionnaire for Rheumatologists

Dear Doctor,
The objective of this questionnaire is to obtain clinical insights to understand the need gap in the management of Rheumatoid Arthritis and to evaluate the usage pattern of Tofacitinib.

Q1: In your practice, how many patients of RA do you see in a week? *

a) <10 b) 10-25 c) 25-50 d) >50

Q2: At what stages of RA do the patients reach you for treatment? *

a) Mild b) Moderate c) Severe

Q3: What is the gender ratio of RA patients? *

	< 25%	25-50%	50-75%	>75%

Male
Female

Q4: What is your preferred treatment option for RA patients? *

	1^st Line	2^nd Line	3^rd Line
Methotrexate

Hydroxychloroquine

Leflunomide

Sulfasalazine

Combination of 2 DMARDs

Combination of 3 DMARDs

Tofacitinib

Q5: If well tolerated, what is the average duration of therapy as per your prescription? *

a) 15 days - 1 month b) 1 month - 3 months c) 3 months - 6 months d) > 6 months

Q6: What % of patients respond to 1st line therapy? *

a) < 25%

b) 25-50%

c) 50-75%

d) > 75%

Q7: In how many RA patients have you prescribed TOFACITINIB? *

a) < 10

b) 10-25

c) 25-50

d) > 50

Q8: What is the average duration of therapy with TOFACITINIB? *

a) 15 days - 1 month

b) 1 month - 3 months

c) 3 months - 6 months

d) > 6 months

Q9: When patients do not respond to 1st line treatment, what is your line of prescription? *

a) Increase the dosage of DMARD's

b) Combine with other DMARDs

c) Switch to Injectable Biologics

d) Refer to Rheumatologist

Q10: In severe RA patients, what is your preference for injectable biologics? *

a) Adalimumab

b) Tocilizumab

c) Itolizumab

d) Infliximab

Others

Questionnaire for Rheumatologists

Dear Doctor, The objective of this questionnaire is to obtain clinical insights to understand the need gap in the management of Rheumatoid Arthritis and to evaluate the usage pattern of Tofacitinib.

Dear Doctor,
The objective of this questionnaire is to obtain clinical insights to understand the need gap in the management of Rheumatoid Arthritis and to evaluate the usage pattern of Tofacitinib.